JAMA Archive
-
September 11, 2014
Vanderbilt’s Heckers named editor-in-chief of JAMA Psychiatry
Stephan Heckers, M.D., M.Sc., William P. and Henry B. Test Professor of Schizophrenia Research and chair of the Department of Psychiatry, has been named the next editor-in-chief of JAMA Psychiatry, one of nine specialty journals in the JAMA Network. -
June 12, 2014
Study tracks insulin’s risks as second-line diabetes medication
In an observational study by researchers at Vanderbilt University Medical Center, adults with type 2 diabetes who take insulin in addition to the recommended first-line drug therapy, metformin, had a 30 percent higher risk of heart attack, stroke or death when compared to similar patients who instead augment their metformin regimen with a sulfonylurea. -
August 22, 2013
Antipsychotic drug use in children for mood/behavior disorders increases type 2 diabetes risk
Prescribing “atypical” antipsychotic medications to children and young adults with behavioral problems or mood disorders may put them at unnecessary risk for type 2 diabetes, a Vanderbilt University Medical Center study shows. -
October 18, 2011
Predicting hospital readmission is risky business: study
Each year millions of Americans return to the hospital within 30 days of their previous discharge. Although many readmissions could be preventable, most statistical models for predicting them "perform poorly," according to researchers at Vanderbilt and the Oregon Health and Science University and their affiliated VA medical centers. -
October 13, 2011
Supplements don’t help lung injury patients
Supplements did not improve outcomes of patients with acute lung injury.